Kasia Lipska, MD
Enriched profileAssociate Professor of Medicine (Endocrinology) · Yale School of Medicine
Kasia Lipska is Associate Professor of Medicine (Endocrinology) at Yale School of Medicine. OpenAlex indexes 218 publications with 7,576 citations (h-index 41); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 10 Oct 2026
Overview
Updated 14 Oct 2026
Kasia Lipska, M.D., is Associate Professor of Medicine (Endocrinology) at Yale School of Medicine. The public record shows 218 publications with 7,576 citations (h-index 41), centered on Diabetes Management and Research, Diabetes Treatment and Management, Diabetes Management and Education. It also documents an investigator role on 3 registered clinical trials, 6 NIH-funded awards (2013–2026).
- Most recent indexed publication: 2026 · Journal of general internal medicine
- Top research focus: Diabetes Management and Research
- 3 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 82.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Sponsor: Yale University
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
79.8%GLP-1 receptor agonist32.5%Ozempic56%Mounjaro44%Part D≥24 patientsInsulin Analog20.2%Lantus Solostar61%Novolog Flexpen20%Tresiba Flextouch U-20019%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
11.6%l-Thyroxine11.6%Levothyroxine Sodium100%Part D<11 patientsCardiovascular
8.6%ACE inhibitor4.5%Lisinopril100%Part D<11 patientsStatin4.1%Rosuvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
6 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- "Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes in Medicare."
Yale University
FY2026$692,186R01DK141666 - Addressing Social Determinants of Health in Young Adults with Type 1 Diabetes Through Comprehensive Assessment, Responsiveness, and Engagement (T1CARE)
Yale University
FY2026$468,180R01DK139558 - Evidence-Based Targets for Continuous Glucose Monitoring Metrics in Adults with Type 1 Diabetes
Kaiser Foundation Research Institute
FY2026$370,000R56DK141601
Congress activity
Updated 14 Oct 2026
24 congress contributions (2018–2026) across ADA, ENDO per OpenAlex. The most recent:
- 1178-OR: Population Impact of State-Level Insulin Out-of-Pocket Caps
ADA Scientific Sessions
ADA2026Co-authorOral - 1927-P: CGMs for All: Studying the Impact of Expanding CGM Access
ADA Scientific Sessions
ADA2026Co-authorPoster - 2092-LB: Association of Fingerstick-Detected Hyperglycemia with Urinary Incontinence in Veterans Affairs Nursing Home Residents—A Case-Crossover Study
ADA Scientific Sessions
ADA2025Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Videographic Analysis of an Intervention to Improve Patient-Centered Care for People Living with Type 2 Diabetes: The QBSAFE Randomized Trial.
Journal of general internal medicine
Article2026 - Out-of-pocket insulin spending before and after the Inflation Reduction Act across demographic subgroups.
Health affairs scholar
Article2026 - Burden of Hypoglycemia and Hyperglycemia in Insulin-Treated Veterans Affairs Nursing Home Residents.
Journal of the American Geriatrics Society
Article2026
Most-cited works
by citation count (OpenAlex)- 01Metformin in Patients With Type 2 Diabetes and Kidney DiseaseArticle604 citations2014
- 02Metformin in 2019Article453 citations2019
- 03Use of Metformin in the Setting of Mild-to-Moderate Renal InsufficiencyArticle435 citations2011
- 04Potential Overtreatment of Diabetes Mellitus in Older Adults With Tight Glycemic ControlArticle405 citations2015
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Awards & honors
honors on the public record- YCCI Scholar2015verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
Secondary affiliations
appointments beyond the home institution- Clinical Investigator
Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harlan Krumholz, MD
Yale School of Medicine
Eric Winer, MD
Yale School of Medicine
Roy Herbst, MD, PhD
Yale School of Medicine
Robert Rosenheck, MD
Yale School of Medicine
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine